Chris Parker BA, BM BChir, MD, FRCR, MRCP

Chris Parker MD was a consultant in Clinical Oncology at the Royal Marsden Hospital and Honorary Senior Lecturer in Prostate Cancer Translational Research at the Institute of Cancer Research, Sutton, United Kingdom.

Dr. Chris Parker received an MB BChir degree from Merton College, Oxford, and subsequently an MRCP and FRCR. He earned an MD degree from the University of London. Prior to his present appointment, he was a Clinical Research Fellow in the Department of Radiation Oncology at Princess Margaret Hospital in Toronto. Earlier, at St. Thomas’ Hospital in London, he served as Specialist Registrar in Clinical Oncology.

Since 2003, Dr. Parker has been a member of the Department of Health Prostate Cancer Advisory Group. For the past 2 years, he has served with the NCRI Prostate Cancer Collaboratives Scientific Advisory Committee. Beginning in 2009, he chaired the MRC Trial Steering Committee for G-I and Gynae trials and has been a member of the Macmillan Cancer Support Clinical Advisory Board. He has been chairman of the RCR Clinical Oncology Research Committee since 2007.